Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Effect Between Quetiapine and Haloperidol on the Treatment of Methamphetamine - Induced Psychosis

NCT01939093 is registered in ClinicalTrials.gov with Chulalongkorn University as lead sponsor.

NCT NCT01939093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01939093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Effect Between Quetiapine and Haloperidol on the Treatment of Methamphetamine - Induced Psychosis
Lead sponsor
Chulalongkorn University
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2010
Completion date
September 30, 2011
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine-induced psychosis